The identification of drug-target Interactions (DTIs) represents a pivotal link in the process of drug development and design. It plays a crucial role in narrowing the screening range of candidate drug molecules, thereby facilitating the reuse of drug, reducing the cost of drug development, and improving the efficiency of drug development.
